Abeona Therapeutics's market cap is currently ―. The company's EPS TTM is $-3.206; its P/E ratio is -1.37; Abeona Therapeutics is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-0.35. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23
Income Statement	-
Total Revenue	-	-	-	$ 3.50M	-
Gross Profit	-	-	-	$ 3.50M	-
EBIT	$ -1.97M	$ -16.48M	$ -11.73M	$ -18.68M	$ 15.07M
EBITDA	$ -1.30M	$ -15.99M	$ -10.77M	$ -17.80M	$ 15.84M
Net Income Common Stockholders	$ -31.58M	$ -16.64M	$ -11.80M	$ -16.65M	$ 14.97M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 62.34M	$ 52.23M	$ 53.75M	$ 36.77M	$ 40.36M
Total Assets	$ 74.83M	$ 64.00M	$ 66.09M	$ 53.55M	$ 53.34M
Total Debt	$ 27.86M	$ 9.98M	$ 5.69M	$ 5.97M	$ 7.32M
Net Debt	$ -34.48M	$ -42.25M	$ -48.06M	$ -30.80M	$ -33.05M
Total Liabilities	$ 83.71M	$ 49.18M	$ 44.05M	$ 44.20M	$ 34.60M
Stockholders Equity	$ -8.88M	$ 14.83M	$ 22.04M	$ 9.35M	$ 18.74M
Cash Flow	-
Free Cash Flow	$ -15.26M	$ -9.26M	$ -5.78M	$ -10.14M	$ -11.96M
Operating Cash Flow	$ -14.54M	$ -9.23M	$ -5.75M	$ -10.28M	$ -11.74M
Investing Cash Flow	$ -7.82M	$ 11.53M	$ -18.74M	$ 5.21M	$ 2.21M
Financing Cash Flow	$ 25.44M	$ 7.47M	$ 22.98M	$ 6.62M	$ -4.00K

Currency in USD

Abeona Therapeutics Earnings and Revenue History

Income Statement >

Abeona Therapeutics Debt to Assets

Balance Sheet >

Abeona Therapeutics Cash Flow

Cash Flow >

Abeona Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing